Clinical Oncology Next Generation Sequencing Market, By Workflow Type (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing), By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Clinical Oncology Next Generation Sequencing Market size was valued at USD 388.4 Million in 2022, expanding at a CAGR of 16.5% from 2023 to 2030.
In the realm of genetic analysis, Next-generation sequencing (NGS), often referred to as massively parallel sequencing, emerges as a cutting-edge technology capable of delving into the extensive genomic data of a tumor. The foundation of most NGS platforms lies in synthesis-based sequencing, harnessing advanced processes to unlock a wealth of genetic insights.
Recent years have witnessed a transformation in the application of NGS, particularly in the field of clinical oncology. This groundbreaking technology has been instrumental in advancing personalized cancer treatment, marking a significant shift towards tailored therapeutic strategies. Within this context, NGS serves multiple crucial purposes, including the identification of familial cancer mutation carriers, the detection of novel and rare cancer mutations, and the provision of molecular insights that underpin effective targeted therapy.
Clinical Oncology Next Generation Sequencing Market- Market Dynamics
- The rising prevalence of cancer is expected to drive the growth of the Clinical Oncology Next Generation Sequencing market.
With the escalating incidence of cancer, there is an increasingly pressing need to gain deeper insights into the disease and explore innovative therapeutic approaches. Next-generation sequencing (NGS) assays have rapidly gained preference in the management of advanced cancer patients. These assays leverage high-throughput DNA sequencing technology to decode the entire genome, the complete exome, or specific gene exons via targeted panels.
In the United States, the year 2020 witnessed a staggering 1,603,844 reported new cases of cancer, with 602,347 individuals succumbing to the disease. This data translates to 403 new cancer cases and 144 cancer-related deaths for every 100,000 people, as reported by the Centers for Disease Control and Prevention. It\'s important to note that the year 2020 is the most recent year for which incidence data are available.
Clinical Oncology Next Generation Sequencing Market- Key Insights
- According to the insights shared by our research experts, the global Clinical Oncology Next Generation Sequencing market is poised for substantial annual growth, with an estimated Compound Annual Growth Rate (CAGR) of approximately 16.5% during the projected period spanning from 2023 to 2030.
- The Clinical Oncology Next Generation Sequencing market is on the brink of rapid expansion, driven by a convergence of technological advancements and an upswing in research investment. This dynamic is setting the stage for remarkable progress within the field.
- In the realm of workflow segmentation, the NGS Sequencing category dominated the landscape in the year 2022, reflecting its significance within the market.
- Within the domain of technology segmentation, both Targeted Sequencing and resequencing technologies emerged as prominent players in the year 2022.
- Furthermore, when examining the application segmentation, Screening made a significant mark as the primary category in the year 2022, emphasizing its relevance in clinical oncology.
Clinical Oncology Next Generation Sequencing Market- Segmentation Analysis:
The Global Clinical Oncology Next Generation Sequencing Market boasts a comprehensive segmentation strategy, with Workflow Type, Application, Technology, End-User, and Region playing pivotal roles.
Within this intricate landscape, the market unfolds into three distinctive categories based on Workflow: NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis. Among these, it\'s the NGS Sequencing segment that commands the market\'s forefront. NGS, a collective term encompassing a range of cutting-edge sequencing technologies, offers substantial advantages over traditional methods. It enables faster and more cost-effective DNA and RNA sequencing, a technological leap that holds the potential to revolutionize the field of genomics. These NGS technologies possess the remarkable capability to simultaneously sequence millions to billions of DNA molecules, thereby paving the way for a new era in genetic research and clinical oncology.
Clinical Oncology Next Generation Sequencing Market- Geographical Insights
In terms of geographical presence, the Clinical Oncology Next-Generation Sequencing market spans across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Each of these regions further unfolds into distinct nations contributing to the market\'s dynamics.
North America is poised to take the lead in steering the growth of the Clinical Oncology Next-Generation Sequencing market. This projection stems from the region\'s escalating investments in research and development, coupled with the mounting burden of cancer cases. The increasing prevalence of cancer in North America necessitates innovative approaches for diagnosis and treatment. Notably, the United States stands out as a major contributor, investing significantly in medical and biotechnology research endeavors, marking the nation as a prominent player in the global landscape of clinical oncology.
Clinical Oncology Next Generation Sequencing Market- Competitive Landscape:
The realm of next-generation sequencing (NGS) technologies is witnessing a remarkable expansion. In the healthcare sector, informed decision-makers seek to grasp the precise dynamics of market growth and forthcoming trends, as this knowledge is instrumental in crafting well-suited strategies and regulations. However, the intricate patterns underpinning this landscape remain somewhat enigmatic.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET KEY PLAYERS
- Illumina, Inc.
- Thermo Fisher Scientific
- Hoffmann-La Roche Ltd.
- Agilent Technologies
- Myriad Genetics
- Foundation Medicine
- Paradigm Diagnostics
- Partek, Inc.
- Pacific Bioscience
- Qiagen N.V.
- Beijing Genomics Institute (BGI)
- Perkin Elmer
- Oxford Nanopore Technologies Ltd.
- Caris Life Sciences
- Eurofins Scientific S.E.
GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW TYPE
- NGS Pre-Sequencing
- NGS Sequencing
- NGS Data Analysis
GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION
- Screening
- Sporadic Cancer
- Inherited Cancer
- Companion Diagnostics
- Other Diagnostics
GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY END-USER
- Hospitals
- Clinics
- Laboratories
GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Clinical Oncology Next Generation Sequencing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Clinical Oncology Next Generation Sequencing Market Snippet by Workflow Type
2.1.2. Clinical Oncology Next Generation Sequencing Market Snippet by Technology
2.1.3. Clinical Oncology Next Generation Sequencing Market Snippet by Application
2.1.4. Clinical Oncology Next Generation Sequencing Market Snippet by End-User
2.1.5. Clinical Oncology Next Generation Sequencing Market Snippet by Country
2.1.6. Clinical Oncology Next Generation Sequencing Market Snippet by Region
2.2. Competitive Insights
3. Clinical Oncology Next Generation Sequencing Key Market Trends
3.1. Clinical Oncology Next Generation Sequencing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Clinical Oncology Next Generation Sequencing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Clinical Oncology Next Generation Sequencing Market Opportunities
3.4. Clinical Oncology Next Generation Sequencing Market Future Trends
4. Clinical Oncology Next Generation Sequencing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Clinical Oncology Next Generation Sequencing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Clinical Oncology Next Generation Sequencing Market Landscape
6.1. Clinical Oncology Next Generation Sequencing Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Clinical Oncology Next Generation Sequencing Market – By Workflow Type
7.1. Overview
7.1.1. Segment Share Analysis, By Workflow Type, 2022 & 2030 (%)
7.1.2. NGS Pre-Sequencing
7.1.3. NGS Sequencing
7.1.4. NGS Data Analysis
8. Clinical Oncology Next Generation Sequencing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
8.1.2. Whole Genome Sequencing
8.1.3. Whole Exome Sequencing
8.1.4. Targeted Sequencing & Resequencing
9. Clinical Oncology Next Generation Sequencing Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
9.1.2. Screening
9.1.2.1. Sporadic Cancer
9.1.2.2. Inherited Cancer
9.1.3. Companion Diagnostics
9.1.4. Other Diagnostics
10. Clinical Oncology Next Generation Sequencing Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
10.1.2. Hospitals
10.1.3. Clinics
10.1.4. Laboratories
11. Clinical Oncology Next Generation Sequencing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Clinical Oncology Next Generation Sequencing Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Illumina, Inc.
12.2.2. Thermo Fisher Scientific
12.2.3. F. Hoffmann-La Roche Ltd.
12.2.4. Agilent Technologies
12.2.5. Myriad Genetics
12.2.6. Foundation Medicine
12.2.7. Paradigm Diagnostics
12.2.8. Partek, Inc.
12.2.9. Pacific Bioscience
12.2.10. Qiagen N.V.
12.2.11. Beijing Genomics Institute (BGI)
12.2.12. Perkin Elmer
12.2.13. Oxford Nanopore Technologies Ltd.
12.2.14. Caris Life Sciences
12.2.15. Eurofins Scientific S.E.
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
